Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Automotive Regulatory News (CTA)

Share Price Information for Ct Automotive (CTA)

Share Price is delayed by 15 minutes
Get Live Data
36.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (5.714%)
Market Cap: £26.50m
CTA Live PriceLast checked at - London Stock Exchange

Intraday Ct Automotive Share Chart

Trading Statement

6 Aug 2025 07:00

RNS Number : 0997U
CT Automotive Group PLC
06 August 2025
 

6 August 2025

 

CT Automotive Group plc

("CT Automotive" or the "Group")

 

Trading Statement

FY25 Earnings on Track as Mexico Facility Ramps Up

 

CT Automotive Group plc ("CT Automotive" or the "Group"), a leading designer, developer, and supplier of interior components to the global automotive industry, is pleased to provide the following trading update for the six months to 30th June 2025.

CT Automotive remains on track to meet latest FY25 market expectations for revenue and profitability. H1 25 revenues are expected to be $54.2 million (H1 24: $60.5 million) reflecting customer program launch timing adjustments and inventory run down. It is expected that this position will normalise during H2. Gross margins continue to improve, building on the efficiency initiatives enacted throughout FY24.

 

CT Automotive continues to successfully navigate a challenging automotive market environment. In H1 25, CT Automotive secured eight new contracts worth approx. $37 million annually,* with four of those contracts set to launch in Q4 2025 or early 2026 as customers look to relocate existing manufacturing programs to our cost-efficient facility in Mexico enabling OEMs to take advantage of USMCA certification. The remaining four programs demonstrate strong endorsement of CT Automotive's customer proposition and are scheduled to launch in 2027 and early 2028 giving strong forward looking revenue visibility.

 

While tariffs have introduced significant uncertainty across the industry, they have also presented opportunities. The success of our Mexico facility in securing new contracts transferring from existing customer programs, reflects this, and highlights the growing appeal of this location. To support this increased demand, the Group is investing $3.4 million in FY25 to further enhance the site's capabilities, including the addition of a new automated paint line and 15 new injection moulding machines.

 

Outlook

 

Across the Group, we continue to deliver efficient, low-cost manufacturing solutions through our three global production centres. The new contract wins demonstrate customer confidence in CT Automotive and provide enhanced revenue visibility for FY25, FY26 and beyond. Combined with continued investment in innovation, and a focus on operational efficiency, the Board remains confident in CT Automotive's outlook and growth prospects.

 

*In aggregate, once all contracts are operational.

  

Listen to CEO Simon Phillips provide further insight on this trading update

Your browser does not support HTML5 video.

 

Note: The Company believes that current market expectations for the year ended 31 December 2025 are for revenues of $122.0m and adjusted Profit Before Tax of $10.5m respectively.

 

Enquiries:

CT Automotive

Simon Phillips, Chief Executive Officer

Salman Mohammed, Chief Financial Officer

Via Novella

 

Singer Capital Markets Advisory LLP (Nominated Adviser and Broker)

Alex Bond, James Todd, Samed Ethemi

 

Tel: +44 (0)20 7496 3000

Novella Communications (Financial Public Relations)

Tim Robertson, Safia Colebrook

Tel : +44 (0)20 3151 7008

ctautomotive@novella-comms.com

 

Notes to editors

CT Automotive is engaged in the design, development and manufacture of bespoke automotive interior finishes (for example, dashboard panels and fascia finishes) and kinematic assemblies (for example, air registers, arm rests, deployable cup holders and storage systems), as well as their associated tooling, for the world's leading automotive original equipment manufacturers ("OEMs") and global Tier One manufacturers.

 

The Group is headquartered in the UK with a low cost manufacturing footprint. Key production facilities are located in Shenzhen and Ganzhou, China with additional manufacturing facilities in Mexico and Türkiye and distribution facilities and assembly lines in Europe, Asia and the US. The Company has a low cost design and administrative centre in India.

CT Automotive's operating model enables it to pursue a price leadership strategy, supplying high quality parts to customers at a lower overall landed cost than competitors. This has helped the Group build a high-quality portfolio of OEM customers, both directly and via Tier One suppliers including Forvia and Marelli.  End customers include volume manufacturers, such as Nissan, Ford, GM and Volkswagen Audi Group, and premium luxury car brands such as Bentley and Lamborghini. In addition, the Group supplies all our customer base with a range of products for PHEV and BEV platforms and supplies electric car manufacturers, including Rivian and a US based major EV OEM.

The Group currently supplies component part types to over 55 different models for 22 OEMs. Since its formation, the Group has been one of the very few new entrants to the market, which is characterised by high barriers to entry.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUGDIGUGDGUU
Date   Source Headline
5th Feb 20137:00 amRNSDirector/PDMR Shareholding
28th Jan 20134:01 pmRNSFinal Results
25th Jan 20133:04 pmRNSDoc re. - FORM 8-K
21st Jan 20137:00 amRNSDoc re. Form 8K
14th Jan 20134:44 pmRNSDirector/PDMR Shareholding
14th Jan 20137:00 amRNSDirector/PDMR Shareholding
10th Jan 20137:00 amRNSDirector/PDMR Shareholding
8th Jan 20137:00 amRNSDirector/PDMR Shareholding
4th Jan 20137:00 amRNSDirector/PDMR Shareholding
21st Dec 20127:00 amRNSDirector/PDMR Shareholding
20th Dec 20122:21 pmRNSForm 8-K, Dealer Stats
19th Dec 20127:00 amRNSDirector/PDMR Shareholding
18th Dec 20127:00 amRNSForm 8-K, Board of Directors/Retirment
12th Dec 20124:36 pmRNSDividend Declaration
5th Dec 20127:00 amRNSDirector/PDMR Shareholding
28th Nov 20122:55 pmRNSDirector/PDMR Shareholding
20th Nov 20122:20 pmRNSDoc re: Form 8-K
20th Nov 20127:00 amRNSDirector/PDMR Shareholding
8th Nov 20127:00 amRNSDirector/PDMR Shareholding
7th Nov 20127:00 amRNSDoc re. Executive Officer Retirement Agreement
7th Nov 20127:00 amRNSDirector/PDMR Shareholding
5th Nov 20127:00 amRNSDirector/PDMR Shareholding
2nd Nov 20125:20 pmRNS3rd Quarter Report 10-Q
2nd Nov 20127:00 amRNSDirector/PDMR Shareholding
22nd Oct 20123:05 pmRNS3rd Quarter Results
22nd Oct 20127:00 amRNSDoc re: Form 8-K filing
15th Oct 20127:00 amRNSOfficer Change
8th Oct 20123:16 pmRNSDividend Declaration
3rd Oct 20127:00 amRNSDirector/PDMR Shareholding
1st Oct 20127:00 amRNSDoc re. Form 8-K Filing
21st Sep 20123:29 pmRNSDoc re. Form 8-K Filing
18th Sep 20127:00 amRNS8-K Filed
6th Sep 20127:00 amRNSDirector/PDMR Shareholding
29th Aug 20127:00 amRNSDoc re: Form 8-K Filing
22nd Aug 20127:00 amRNSDirector/PDMR Shareholding
21st Aug 20127:00 amRNSDoc re. Form 8-K Filed
21st Aug 20127:00 amRNSDoc re Form 8-K Filing
13th Aug 20127:00 amRNSDoc re: Form 8-K Filing
7th Aug 20127:00 amRNSDoc re. Half Yearly Report
3rd Aug 20127:00 amRNSDirector/PDMR Shareholding
2nd Aug 20127:00 amRNSDirector/PDMR Shareholding
30th Jul 20127:00 amRNSDoc re Form 8-K Filing
25th Jul 20122:39 pmRNSHalf Yearly Report
4th Jul 20127:00 amRNSDirector/PDMR Shareholding
26th Jun 20127:00 amRNSDoc re. Form 8-K filed
13th Jun 20126:06 pmRNSDividend Declaration
6th Jun 20127:00 amRNSDirector/PDMR Shareholding
9th May 20127:00 amRNSDirector/PDMR Shareholding
8th May 20127:00 amRNS1st Quarter Report on Form 10-Q (excluding RNA)
4th May 20127:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.